Search
GLPG-0259
go.drugbank.com/drugs/DB15190InvestigationalGLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
Etozoline
go.drugbank.com/drugs/DB08982ExperimentalEtozoline is marketed in Europe under the names Diulozin, Elkapin, and Etopinil. Etozoline is a loop diuretic.
Selenomethionine Se-75
go.drugbank.com/drugs/DB09400ApprovedCategories: Amino Acids, Peptides, and ProteinsDectrekumab
go.drugbank.com/drugs/DB14789InvestigationalDectrekumab is under investigation in clinical trial NCT00987545 (Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence).
Nitecapone
go.drugbank.com/drugs/DB20402ExperimentalNitecapone is a small molecule drug. Nitecapone has a monoisotopic molecular weight of 265.06 Da.
Categories: Compounds used in a research, industrial, or household settingOmecamtiv Mecarbil
go.drugbank.com/drugs/DB11816InvestigationalOmecamtiv Mecarbil has been used in trials studying the treatment and basic science of Heart Failure, Echocardiogram, Pharmacokinetics, Chronic Heart Failure, and History of Chronic Heart Failure, among
Incyclinide
go.drugbank.com/drugs/DB11647InvestigationalIncyclinide has been used in trials studying the treatment of HIV Infection, AIDS-related Kaposi Sarcoma, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific.
Apricoxib
go.drugbank.com/drugs/DB12378InvestigationalApricoxib has been used in trials studying the treatment and prevention of Lung Cancer, Breast Cancer, Pancreatic Cancer, Non Small Cell Lung Cancer, and Metastatic Pancreatic Cancer, among others.
N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium
go.drugbank.com/drugs/DB03945InvestigationalCalcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
Synonyms: Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-, N,N,N-Trimethyl-2-(phosphonooxy)ethanaminiumPF-06273340
go.drugbank.com/drugs/DB12269InvestigationalPf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects … of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)).